RANCHO CUCAMONGA, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months and fiscal year ended December 31, 2016.
Fourth Quarter Highlights
* Net revenues of $63.5 million for the fourth quarter
* GAAP net loss of $2.7 million, or $0.06 per share, for the fourth quarter
* Adjusted non-GAAP net income of $0.5 million, or $0.01 per diluted share, for the fourth quarter
Fourth Quarter Highlights
* Net revenues of $63.5 million for the fourth quarter
* GAAP net loss of $2.7 million, or $0.06 per share, for the fourth quarter
* Adjusted non-GAAP net income of $0.5 million, or $0.01 per diluted share, for the fourth quarter
